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Surveillance for lyssaviruses was conducted among
bat populations in 8 provinces in Thailand. In 2002 and
2003, a total of 932 bats of 11 species were captured and
released after serum collection. Lyssavirus infection was
determined by conducting virus neutralization assays on
bat serum samples. Of collected samples, 538 were either
hemolysed or insufficient in volume, which left 394 suitable
for analysis. These samples included the following:
Pteropus lylei (n = 335), Eonycteris spelaea (n = 45),
Hipposideros armiger (n = 13), and Rousettus leschen-
naulti (n = 1). No serum samples had evidence of neutral-
izing antibodies when tested against rabies virus. However,
16 samples had detectable neutralizing antibodies against
Aravan virus, Khujand virus, Irkut virus, or Australian bat
lyssavirus; all were specifically associated with fruit bats P.
lylei (n = 15) and E. spelaea (n = 1). These results are con-
sistent with the presence of naturally occurring viruses
related to new putative lyssavirus genotypes. 
R
abies is an acute encephalitis caused by a lyssavirus.
On a global basis, bats have been associated with sev-
eral different genotypes of lyssavirus (1–5). Two human
infections with Australian bat lyssavirus (ABLV) have
been reported, the clinical signs of which were consistent
with classical rabies infection, namely a diffuse, nonsup-
purative encephalitis(3). Aserosurvey for agents similar to
ABLV among bats in the Philippines detected a prevalence
of 9.5% (22/231) (6). Six of 14 species (fruit- and insect-
eating bats) were seropositive for reactivity against ABLV.
These included Taphozous melanopogan (4/30),
Mineopterus schreibersi (4/11),  Philetor brachypterus
(1/13), Scotophilus kuhlii (4/63), Pteropus hypomelanus
(3/14), and Rousettus amplexicaudatus (6/50) (6).
However, Asian bat lyssaviruses (1,2,4) were unavailable
at that time to check for cross-reactivity.
Canine rabies is enzootic in Thailand. No bat-associated
rabies or lyssavirus deaths in have been reported in humans
or other animals (7).This lack of data for other agents, how-
ever, does not exclude their existence (1). Rabies statistics
in humans and animals are underreported (8). Moreover,
without a history of dog bite, rabies may be dismissed, or
clinical manifestations of bat-related cases may be variable
(8). In the context of bat lyssavirus as an emerging global
infectious disease, baseline data are necessary to allow for
future public health assessment of its impact. This active
surveillance sought to determine whether bats in Thailand
had evidence of lyssavirus infections.
Methods
Collection of Specimens
From March 2002 through August 2003, bats were col-
lected from 8 provinces throughout central, eastern, and
southern Thailand (Figure 1). Sites were chosen on the
basis of local reports of known bat colonies or after inves-
tigation by the Royal Department of Forestry, Ministry of
Agriculture. Insectivorous bats in caves were captured dur-
ing the day by using fine-mesh, long-handled butterfly
nets. Larger fruit bats were captured with nets near sunset,
as the bats flew for foraging activities, or before dawn
when returning to their roosts (Figure 2). Thick leather
gloves were worn when bats were handled and transferred
into individual cotton pouches for transportation and pro-
cessing.
Of the 932 bats collected, all were identified to 11 dif-
ferent species of both insectivorous and frugivorous bats
(Table 1). Forty percent were female. All bats appeared
healthy. At least 110 bat species (>20 million) are believed
to be present in Thailand, according to estimates from a
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Bats were anesthetized by administering a 0.2- to 0.5-
mg intramuscular injection of ketamine hydrochloride.
Animals were identified to sex and by species, based on
gross morphology, as described (9). Animals were marked
by hair or claw clipping. Blood, obtained from wing veins
or by direct cardiac puncture, was transferred from the col-
lecting syringe into 1.5-mL microtubes (Axygen
Scientific, Union City, CA, USA) and stored in an icebox
until centrifugation. Serum was frozen at –20°C during
transportation and stored in a freezer at –70°C. After
recovery from sedation, bats were allowed to fly to their
roosts. Sixteen of 932 died during the capture process.
Inspection of the capture sites 1–2 months later included
an assessment of whether the local ecology was disturbed.
No additional bats died after the procedure, according to
residents living near roosts.
Serologic Testing for Neutralizing Antibodies
Serum specimens were obtained from blood samples
after clotting. In general, 394 samples from 4 different
species were of sufficient volume and quality (Table 2).
The samples originated from Chonburi (n = 167), Ayuttaya
(n = 105), Chachoengsao (n = 36), Singburi (n = 81), and
Surattani (n = 5). For adequate volume during testing, they
were diluted 1:5 in Eagle’s minimum essential medium
(Invitrogen, Carlsbad, CA, USA) supplemented with 2%
fetal bovine serum (Invitrogen). Serum samples were heat-
inactivated for 30 min at 56°C before testing. 
Initially, all 394 samples were screened in a modified
rapid fluorescent focus inhibition test (6) against rabies
virus (RABV, strain CVS-11) and ABLV (pteropid sub-
type; 40 50% tissue culture infective dose), with World
Health Organization standard serum as a source for posi-
tive control antibody with 50% endpoint dilution of 1 IU =
1:20. Approximately 50 µL of diluted serum at 1:5, 1:10,
and 1:20 dilutions was incubated with 50 µL of ABLV in
96-well microtiter plates for 90 min at 37°C in a CO2 incu-
bator. Murine neuroblastoma cells (50 µL) were added to
each serum-virus mixture, which was incubated for 20 h.
Culture medium was removed after incubation, and the
plates were fixed with 90% acetone, air-dried, and then
stained with fluorescein isothiocyanate–conjugated anti-
rabies monoclonal antibodies (Fujirebio Diagnostic, Inc,
Malvern, PA, USA). Samples were considered positive if
the number of fluorescent foci was reduced by 50% at the
1:5 dilution. 
Those samples that demonstrated positive or suspicious
activity were additionally tested against a broader panel of
other lyssaviruses, including Aravan, Khujand, and Irkut
virus isolates. Twofold serum dilutions, from 1:25 to 1:100,
were tested, and virus doses varied from 32 to 100 infec-
tious units. These reactions were performed by using drops
of cell culture medium on 4-well (6-mm) Teflon-coated
glass slides (Cell-line/Erie Scientific Co., Portsmouth, NH,
USA), incubated in a moist chamber for 48 h.
Direct Fluorescent Antibody (DFA) 
and Mouse Inoculation (MI) Testing of Brains
Brains from 16 dead bats (2 P. lylei and 14 P. hypome-
lanus) were collected in iceboxes at the capture sites for
transportation and then were stored at –70°C until testing.
Each brain was tested for lyssavirus antigen by DFA.
Multiple impressions were prepared, and slides were fixed
in acetone, allowed to dry at room temperature, and stained
with commercial fluorescein isothiocyanate–conjugated
anti-rabies monoclonal antibodies (Fujirebio Diagnostic,
Inc). These brain impressions were examined with a fluo-
rescent microscope.
For MI testing, pooled 20% brain suspensions from all
16 bats were prepared by mixing ≈0.5 g of each bat brain
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Figure 1. Map of Thailand showing bat collection sites from 8
provinces and locations of bats found seropositive. 1 = Chonburi,
2 = Singburi, 3 = Ayuttaya, 4 = Chachongsao, 5 = Rayong, 6 =
Prachinburi, 7 = Ratchaburi, 8 = Suratthani.
Pteropus lylei
Eonycteris spelaeain 32 mL of normal saline solution. No antimicrobial
preparations were added. The mixture was left to sediment
at room temperature for 30 min, and the supernatant was
used to inject into the brains of 1-month-old Swiss albino
strain mice. Approximately 0.03 mL of each suspension
was injected into each of 30 mouse brains. They were kept
in 6 glass jars (5 in each) with a diameter of 15 cm and
were observed for 60 days.
Results
Serologic Testing
All 394 serum samples were negative against RABV,
but 16 (4%) were positive or suggestive of ABLV(Table 2).
Further tests of these samples demonstrated neutralizing
activity against Aravan, Khujand, or Irkut viruses or ABLV
(Table 3). These 16 samples originated from 2 species, P.
lylei (n = 15) and Eonycteris spelaea (n = 1), collected at
Chonburi (n = 9), Singburi (n = 4), Ayuttaya   (n = 2), and
Chachoengsao (n =1) Provinces (Table 2).
Chonburi is adjacent to Chachoengsao Province in the
east, whereas Singburi and Ayuttaya are both located in the
central part of the country (Figure 1). Approximately 5%
of positive bat serum specimens were found in 2 eastern
provinces (Chonburi, 9/158 and Chachoengsao, 1/36) ver-
sus 3% in 2 central provinces (Singburi, 4/81, and
Ayuttaya, 2/105). Antibody-positive bats were dispersed
throughout the collection period (March 2002 through
August 2003). Most (15 of 16) positive samples came from
P. lylei. One of 45 E. spelaea (versus 15 of 335 P. lylei)
tested positive.
DFA and MI Testing
Sixteen bat brains tested by DFA had no detectable
lyssavirus antigen. After intracerebral injection, 4 of 30
mice died, on days 11, 12, 14, and 21, respectively. None
of these 4 brains tested positive with DFA for evidence of
lyssavirus antigens.
Discussion
This study presents evidence of neutralization of
lyssaviruses other than RABV and ABLV by sera from
Thai bats. These findings are consistent with the presence
of naturally induced antibodies against >1 lyssavirus geno-
type in the Thai bat populations studied.
Lyssaviruses are classified into groups on the basis of
their genetic, antigenic, and relative pathogenic attributes.
At least 7 putative genotypes and 2 major phylogroups are
recognized on the basis of their overall phylogenetic
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Figure 2. Thai Flying foxes (Pteropus lylei) at their roost.relatedness (1). Phylogroup I includes RABV (genotype
1), Duvenhage virus (DUVV) (genotype 4), European bat
lyssavirus (EBLV) 1 (genotype 5), EBLV-2 (genotype 6),
and ABLV (genotype 7). Phylogroup II includes Lagos bat
virus (LBV) (genotype 2) and Mokola virus (MOKV)
(genotype 3) (10). In this study, neutralization titers to new
putative genotypes, namely, Irkut, Khujand, and Aravan
viruses, and of much lesser degree to ABLV but not to
RABV, were evident. Khujand virus is related to genotype
6, while Aravan virus is related to Khujand virus, with
moderate similarity to genotypes 4, 5, and 6 (2,4). ABLV
is more closely related to RABV (3). When a comparative
phylogenetic analysis was performed, Irkut virus was rec-
ognized as a member of a cluster joining lyssavirus geno-
types 4 and 5 (76% bootstrap support) (1).
This preliminary study demonstrates that which virus is
used for a serologic test is critical. All Thai samples were
negative to RABV and most to ABLV, findings which help
explain why lyssavirus infection has not previously been
reported in Thai bats. A relatively low prevalence of
lyssavirus infection in Thai bats in the current study (4%
as compared to 9.5% in the Philippines survey [6]) may be
explained by the fact that as many as 43 samples had a 1:5
(some of them, both 1:5 and 1:10) dilution considered
unreadable because of the effect of hemolysis. Moreover,
another 13 samples with equivocal result were seropositive
for ABLV after subsequent testing. Further testing of these
additional 13 samples against Irkut, Khujand, and Aravan
viruses was not possible because of insufficient volume.
Therefore, the actual positive number might be 29 (7.3%)
of 396. Nevertheless, without a Thai lyssavirus isolate,
concluding to which virus these bats have been exposed is
difficult. These data also suggest that several lyssaviruses
are in circulation throughout Thailand as well as other
Asian countries, such as in the Philippines, Central Asia,
and portions of Russia (1,2,4,6).
Further studies throughout the year should be expanded
to other species of bats, as well as a focus upon bats such
as P. lylei and in locations with the highest prevalence of
neutralizing antibodies. Whether P. lylei is the single most
important species is not known. Surveillance among sick
and dying bats and collection of their brains would assist
in identifying infecting viruses.
Public health authorities need to be aware of the poten-
tial for bats to transmit lyssaviruses, and to increase sur-
veillance and public education. Attention should focus on
the protective efficacy of commercially available vaccines
and immune globulins against these novel nonrabies
lyssaviruses after exposure, before fatal human infection
occurs.
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